7 completed. 7 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 7 | Completed 7 |
Follow Brain Tumor: new trials by email Literature Review of Brain Tumor trials Research Report on Brain Tumor
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Perioperative Magnesium Sulphate as a Cerebral Protector in Neurosurgical Patients Magnesium Sulfate, Sodium Chloride - Seizures (Incl Subtypes), Brain Tumor | Phase 3 | Completed | Sara Varea | 55 | 2012-10-01 | 2018-01-17 |
| Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy sodium thiosulfate, examination - Brain Tumor, Central Nervous System Tumor | Phase 3 | Completed | Children's Oncology Group | 131 | 2008-06-23 | 2023-11-09 |
| Radiation Therapy Compared With Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Primary Central Nervous System (CNS) Germ Cell Tumor filgrastim, carboplatin, cisplatin - Brain Tumor, Central Nervous System Tumor | Phase 3 | Completed | Children's Oncology Group | 24 | 2007-01-01 | 2018-09-07 |
| An Open-Labeled, Extended-Use of XERECEPT (hCRF) for Patients in Studies NTI 0302, 0303, or Other Designated Studies hCRF [XERECEPT (corticorelin acetate injection)] - Brain Edema, Brain Tumor | Phase 3 | Completed | Celtic Pharma Development Services | 112 | 2005-07-01 | 2012-08-31 |
| High-Dose Chemotherapy Plus Autologous Stem Cell Transplantation Compared With Intermediate-Dose Chemotherapy Plus Autologous Stem Cell Transplantation With or Without Isotretinoin in Treating Young Patients With Recurrent High-Grade Gliomas filgrastim, carboplatin, etoposide - Brain Tumor, Central Nervous System Tumor | Phase 3 | Completed | Children's Oncology Group | 1 | 2004-10-01 | 2015-05-07 |
| XERECEPT® (hCRF) for Patients Requiring Dexamethasone to Treat Edema Associated With Brain Tumors hCRF, placebo hCRF - Brain Edema, Brain Tumor | Phase 3 | Completed | Celtic Pharma Development Services | 200 | 2004-05-01 | 2014-08-13 |
| Serial CT Scans in Fractionated Stereotactic Radiotherapy Relocatable fixation system - Brain Tumor | Phase 3 | Completed | Maastricht Radiation Oncology | 20 | 2003-11-01 | 2009-06-30 |
Brain Neoplasms (7) · Astrocytoma (3) · Central Nervous System Neoplasms (3) · Brain Edema (2) · Edema (2) · Hepatoblastoma (1) · Liver Neoplasms (1) · Medulloblastoma (1) · Neuroblastoma (1) · Osteosarcoma (1) · Ototoxicity (1) · Ovarian Germ Cell Cancer (1) · Ovarian Neoplasms (1) · Sarcoma (1) · Seizures (1)
Brain Diseases (7) · Central Nervous System Diseases (7) · Neoplasms (7) · Neoplasms by Site (7) · Nervous System Diseases (7) · Nervous System Neoplasms (7) · Central Nervous System Neoplasms (4) · Glioma (4) · Neoplasms by Histologic Type (4) · Neoplasms, Germ Cell and Embryonal (4) · Neoplasms, Glandular and Epithelial (4) · Neoplasms, Nerve Tissue (4) · Neoplasms, Neuroepithelial (4) · Neuroectodermal Tumors (4) · Pathological Conditions, Signs and Symptoms (4)
Carboplatin (2) · Corticotropin-Releasing Hormone (2) · Etoposide (2) · Filgrastim (2) · Granulocyte Colony-Stimulating Factor (2) · etoposide phosphate (2) · Cisplatin (1) · Cyclophosphamide (1) · Isotretinoin (1) · Magnesium Sulfate (1) · Peripheral Blood Stem Cell Transplantation (1) · Radiotherapy (1) · Restraint, Physical (1) · Sodium Chloride (1) · Thiotepa (1)
Children's Oncology Group (3) · Celtic Pharma Development Services (2) · Maastricht Radiation Oncology (1) · Sara Varea (1)
Canada (5) · United States (5) · Australia (3) · Netherlands (1) · Puerto Rico (1) · Spain (1)
William Shapiro, MD (2) · Brigitta Baumert, PHD (1) · David R. Freyer, DO, MS (1) · Jeffrey C. Allen, MD (1) · Neus Fabregas, MD PhD (1) · Sharon L. Gardner, MD (1) · Ziad Khatib, MD (1)
PMID 22194025, PMID 23382470, PMID 27914822
U10CA098543 (1)